首页> 外文期刊>international journal of clinical and experimental medicine >Effects of standard treatment combined with leflunomide and glucocorticoids on urinary protein, serum creatinine and urea nitrogen levels in patients with chronic nephritis: a comparison study
【24h】

Effects of standard treatment combined with leflunomide and glucocorticoids on urinary protein, serum creatinine and urea nitrogen levels in patients with chronic nephritis: a comparison study

机译:标准治疗联合来氟米特和糖皮质激素对慢性肾炎患者尿蛋白、血清肌酐和尿素氮水平的影响:比较研究

获取原文
获取原文并翻译 | 示例

摘要

abstract_textpObjective: To investigate the effects of additional leflunomide and glucocorticoids on urinary protein, serum creatinine and urea nitrogen levels in patients with chronic nephritis. Methods: Eighty patients with chronic nephritis who were treated in our hospital from May 2004 to May 2006 were randomly divided into standard treatment (ST) group and ST combined with leflunomide and glucocorticoids treatment (LG) group (n=40 for each group) for four months. Inter-group differences in clinical efficacy and the incidences of adverse events were compared. Results: Compared with ST, patients receiving LG treatment showed lower urinary protein, serum creatinine and urea nitrogen levels (P=0.016, 0.021 and 0.014 respectively). Total remission rate (97.5) in the LG group was significantly higher than that in the RT group (77.5, P=0.023). The incidence of adverse reactions (7.5) in LG group was lower than that in the RT group (22.5, P=0.036) and five-year and ten-year survival rates in the LG group were significantly higher than those in the LG group (P=0.041 and 0.026 respectively). Conclusion: Leflunomide, glucocorticoids combined with ST was more effective and safer for patients with chronic nephritis compared with ST./p/abstract_text
机译:目的:探讨加用来氟米特和糖皮质激素对慢性肾炎患者尿蛋白、血清肌酐和尿素氮水平的影响。方法:选取2004年5月至2006年5月在我院接受治疗的80例慢性肾炎患者,随机分为标准治疗组(ST)组和ST联合来氟米特和糖皮质激素治疗组(LG)组(每组n=40),为期4个月。比较临床疗效和不良事件发生率的组间差异。结果:与ST组相比,LG组患者的尿蛋白、血清肌酐和尿素氮水平降低(P=0.016、0.021和0.014)。LG组总缓解率(97.5%)明显高于RT组(77.5%,P=0.023)。LG组不良反应发生率(7.5%)低于RT组(22.5%,P=0.036),LG组5年和10年生存率均显著高于LG组(P=0.041和0.026)。结论:来氟米特、糖皮质激素联合ST治疗慢性肾炎患者与ST相比效果更好,安全性更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号